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Advances in neonatal intensive care have 
improved survival of preterm infants.[1] Despite 
these advances, neonatal infection remains an 
important cause of mortality, morbidity and 
prolonged hospital stays.[2,3]
Blood cultures are the most direct method of detecting 
bacteraemia in patients.[4] Contaminated blood culture results 
can be troublesome for clinicians attempting to determine 
whether the organism represents a significant infection 
requiring intervention or is merely a false-positive result with 
no consequence to the patient. Reducing contamination rates 
will improve the specificity of the blood culture and result in a 
higher positive predictive value, resulting in a significantly more 
useful test.[5]
To guide empirical antibiotic treatment, infection surveillance 
is important to monitor infection rates, patterns of sensitivity 
profiles and infection control measures. It can also be used for 
benchmarking practice and for interventional studies.[6]
Clinical performance dashboards that present and benchmark 
performance against a series of key indicators have been shown to be 
powerful tools in improving patient care and outcomes.[7]
We evaluated the impact of prospective surveillance 
of bloodstream infections (BSIs), the introduction of an 
educational intervention and the use of a clinical performance 
dashboard on the total number of BSIs and blood culture 
contamination rates.
Methods
The study was conducted at the tertiary-level neonatal unit at 
Groote Schuur Hospital (GSH), Cape Town, South Africa (SA), 
over a 31-month period. The study was approved by the Human 
Research Ethics Committee, Faculty of Health Sciences, University 
of Cape Town.
The total number of blood cultures performed and the number 
of cultures yielding growth were extracted from the National Health 
Laboratory Service microbiology laboratory database on a monthly 
basis. BSI was defined as a positive blood culture including fungal 
organisms. If multiple blood cultures were taken within a 48-hour 
period and contained the same organism, we considered this a 
single BSI.
A positive blood culture was considered to be a contaminant if any of 
the following organisms was detected: alpha-haemolytic streptococci, 
Micrococcus spp., Propionibacterium spp., Corynebacterium spp., 
Bacillus spp., and sometimes enterococci and Acinetobacter spp., 
depending on the clinical status of the patient.[5] In cases of coagulase-
negative Staphylococcus-positive blood cultures, the cultures were 
classified as contaminants if serial serum C-reactive protein levels 
measured 24 hours apart were <10 mg/L, if repeated blood cultures 
remained negative, or if the attending clinician did not initiate 
antibiotic treatment because the infant did not have clinical features 
of sepsis.[8]
We examined and compared two time periods, period 1 (January 
2010 - April 2011) before any intervention, and period 2 (May 2011 - 
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Background. Blood cultures are the most direct method of detecting bacteraemia. Reducing contamination rates improves the specificity 
and positive predictive value of the blood culture. Clinical performance dashboards have been shown to be powerful tools in improving 
patient care and outcomes.
Objectives. To determine whether prospective surveillance of bloodstream infections (BSIs), introduction of an educational 
intervention and the use of a clinical performance dashboard could reduce BSIs and blood culture contamination rates in a neonatal 
nursery.
Methods. We compared two time periods, before and after an intervention. Blood culture data were extracted from the local microbiology 
laboratory database. The educational intervention included the establishment of hand-washing protocols, blood culture techniques and 
video tools. A clinical performance dashboard was developed to demonstrate the monthly positive blood culture and contamination rates, 
and this was highlighted and referred to weekly at the unit staff meeting.
Results. Before the intervention, 1 460 blood cultures were taken; 206 (14.1%) were positive, of which 104 (7.1% of the total) were 
contaminants. In the period following the intervention, 1 282 blood cultures were taken; 131 (10.2%) were positive, of which 42 (3.3% 
of the total) were contaminants. The number of positive blood cultures and contamination rates after the intervention were both 
statistically significantly reduced (p=0.002 and p<0.001, respectively).
Conclusion. This study demonstrates that adopting a relatively simple educational tool, making use of a clinical performance dashboard 
indicator and benchmarking practice can significantly reduce the level of neonatal sepsis while also reducing contaminated blood 
cultures.
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July 2012) following the introduction of an 
educational intervention and use of a clinical 
performance dashboard.
The intervention included written policies 
prioritising and re-enforcing hand washing 
and a ‘bare-below-elbows’ approach, establi-
shing uniform blood culture technique, 
appropriate antibiotic use, and insertion 
and management of central lines according 
to a standardised protocol. Video material 
was used to demonstrate the techniques 
described in the above protocols. A clinical 
performance dashboard was developed as 
a visual aid to demonstrate the monthly 
positive blood culture and contamination 
rates, and this was highlighted and referred 
to weekly at the neonatal unit staff meeting. 
We calculated a baseline median for the 
number of BSIs in the unit for the period 
January - December 2010. The median was 
calculated annually and only adjusted if it 
was less than that in the previous year. This 
‘rolling’ median served as the benchmark 
against which performance was monitored. 
The clinical performance dashboard 
provided the nursing and medical staff in the 
neonatal unit with a real-time, instantaneous 
picture of their performance with regard to 
the total number of positive blood cultures 
and the contamination rates. These data 
were visually displayed using a colour-coded 
system: green, when the total number of 
positive blood cultures was less than the 
median; blue, when the total number of 
positive blood cultures equalled the median; 
and red, when the total number of positive 
blood cultures breached the median. Fig. 1 
illustrates how the dashboard was utilised in 
the neonatal unit.
Data analysis
The microbiology laboratory data were 
exported to a Microsoft Excel file. Data 
were analysed with Stata version 12 (Stata 
Corporation, USA). Chi-square and Fisher’s 
exact tests were used for comparison of 
categorical variables. Descriptive results 
are expressed as numbers and proportions 
(%). A p-value of <0.05 was considered 
significant.
Results
During period 1, 1 460 blood cultures were 
taken; 206 (14.1%) were positive, of which 
104 (7.1% of the total) were contaminants. 
During period 2, following the introduction 
of an educational intervention and use of 
a clinical performance dashboard, 1 282 
blood cultures were taken; 131 (10.2%) were 
positive, of which 42 (3.3% of the total) 
were contaminants. There were statistically 
significant reductions in BSIs (p=0.002) and 
blood culture contamination rates (p<0.001) 
between the pre- and post-intervention 
periods. Fig. 2 illustrates the decline in 
BSIs and blood culture contamination 
rates following the intervention. While the 
total number of blood cultures taken in 
the neonatal unit fluctuated from month 
to month, over the study period the 
Fig. 1. The performance dashboard, a visual indicator tool displayed in the neonatal unit at Groote 
Schuur Hospital. Values written in green indicate months in which positive cultures were below the 
median number of positive cultures. Red values are used to indicate months when positive cultures were 
above the median benchmark.
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Fig. 2. Percentages of positive cultures and contaminants before and after intervention.
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Fig. 3. Monthly trend of total, positive and contaminated blood cultures.
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general trend between period 1 and period 2 remained unchanged. 
Importantly, the admission rates and referral patterns remained 
unchanged during the two study periods, suggesting that the 
workload and clinical indications for taking the blood culture were 
similar for period 1 and period 2. Fig. 3 illustrates the relationship 
between the total number of blood cultures taken, BSIs and 
contaminated blood cultures.
Discussion
Improving the quality and safety of healthcare services is of para-
mount importance. Surveillance and monitoring of key indicators 
is central in achieving this, as it allows for benchmarking and 
performance comparison. Even more important is identifying and 
implementing interventions that impact significantly on these key 
indicators. A rapidly growing body of evidence suggests that quality 
improvement strategies in a variety of clinical settings, including 
neonatal care, are effective and improve patient outcomes while also 
reducing costs.[6]
Our study demonstrates a significant measurable reduction in the 
total number of neonatal BSIs and blood culture contamination rates. 
This is an important outcome, as Modi and Carr[9] and Stoll et al.[10] 
documented neonatal BSI rates for all neonates of 10 - 25% and rates 
as high as 50% in extremely preterm infants. In a recent meta-analysis, 
Bakhuizen et al.[11] concluded that neonatal BSI is associated with an 
increased risk of mortality and severe short- and long-term outcomes.
Contaminated blood cultures have a significant impact on the 
patient and, also importantly, on cost. Compared with truly negative 
cultures, false-positive cultures increase laboratory workload, prolong 
patient stay and increase the use of broad-spectrum antibiotics, 
with negative consequences for antibiotic resistance and patient 
morbidity.[12] The American Society for Microbiology suggests 
contamination rates of <3% for all blood cultures taken.[5] We 
reduced the blood culture contamination rate from 7% to 3.3%. Hand 
washing is recognised as the single most effective method of reducing 
the transmission of micro-organisms between patients, and is an 
integral part of hospital infection control measures.[13] Blood culture 
contamination is a result of poor techniques of hand washing, skin 
cleaning and venepuncture.[12]
An essential part of our stratagem of reducing BSI and contamination 
was the clinical performance dashboard. The high visual impact of the 
dashboard permitted nursing and medical staff to benchmark their 
performance against the set threshold and helped drive performance 
excellence. The dashboard also served as an excellent communication 
tool; night staff in particular benefited from this, as they were often 
unable to attend the neonatal unit staff meetings during normal 
working hours. The dashboard provided the unit with real-time data 
allowing us to anticipate and recognise problems earlier (e.g. when BSI 
results equalled the median or breached the median) and consequently 
to rectify these problems more timeously.
Study limitations
This study does have limitations. It did not quantify the impact of the 
intervention on hospital resource utilisation, particularly length of 
hospital stay, antibiotic utilisation and cost-effectiveness. In addition, 
it did not explore the impact that reduction of BSIs and blood culture 
contamination rates had on mortality and short- and long-term 
morbidities.
Conclusion
This study demonstrates that adopting a relatively simple educa tional 
tool, utilisation of a clinical performance dashboard indicator and 
benchmarking practice can significantly reduce the level of neonatal 
sepsis while also reducing contaminated blood cultures. This 
stratagem was based on intensive collaboration with, and among, all 
levels of staff over the study period and continues to prove successful 
in our endeavours to reduce infection rates in the GSH neonatal unit. 
Given the impact of neonatal BSIs on patient outcomes and hospital 
resource utilisation, the establishment of local and national neonatal 
infection surveillance networks, with similar interventions to those 
we report, is imperative to monitor the epidemiology of neonatal 
infections in SA and inform policy and clinical practice. Integrating 
and leveraging quality improvement benchmarks derived from 
surveillance and monitoring into clinical performance dashboards 
can drive initiatives aimed at excellence within all spheres of 
healthcare services, at both local and national levels.
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